ATA Guidelines Tools

Hyperthyroidism

American Thyroid Association Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/751899

Contents of this Issue

Navigation

Page 11 of 33

12 Table 6. Assessment of GO: Clinical Activity Score Elements Elements a Each visit Comparison with previous visit Score Painful feeling behind the globe over last 4 weeks × 1 Pain with eye movement during last 4 weeks × 1 Redness of the eyelids × 1 Redness of the conjunctiva × 1 Swelling of the eyelids × 1 Chemosis (edema of the conjunctiva) × 1 Swollen caruncle (flesh body at medial angle of eye) × 1 Increase in proptosis ≥2 mm × 1 Decreased eye movements ≥5° any direction × 1 Decreased visual acuity ≥1 line on Snellen chart × 1 a A 7-point scale (excluding the last three elements) is used when no previous assessment is available. GO is considered active in patients with a CAS ≥3. Sources: Adapted from Mourits et al. Br J Ophthalmol. 1989;73:639-644. and Mourits et al. Clin Endocrinol. (Oxf ) 1997;47:9-14. Graves' Disease Graves' Orbitopathy (GO)

Articles in this issue

Archives of this issue

view archives of ATA Guidelines Tools - Hyperthyroidism